Commentary: Pharmacoeconomics and Outcomes Research: Expanding the Healthcare “Outcomes” Market
Open Access
- 1 May 2000
- journal article
- Published by Elsevier in Value in Health
- Vol. 3 (3) , 181-185
- https://doi.org/10.1046/j.1524-4733.2000.33003.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Willingness to Pay versus Willingness to Buy: What Defines Value in Healthcare?Value in Health, 1998
- A Managed Care PerspectiveValue in Health, 1998
- S24 Risk factor management in CHD patients in Asia: current statusAtherosclerosis, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Task force 8. Organization of preventive cardiology serviceJournal of the American College of Cardiology, 1996
- Vitamin E Consumption and the Risk of Coronary Heart Disease in MenNew England Journal of Medicine, 1993
- Vitamin E Consumption and the Risk of Coronary Disease in WomenNew England Journal of Medicine, 1993
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988